• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 Lambda 变体表现出增强的感染力和免疫抗性。

The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance.

机构信息

Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan.

Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan; Laboratory of Systems Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 6068507, Japan; Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 6068501, Japan.

出版信息

Cell Rep. 2022 Jan 11;38(2):110218. doi: 10.1016/j.celrep.2021.110218. Epub 2021 Dec 18.

DOI:10.1016/j.celrep.2021.110218
PMID:34968415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8683271/
Abstract

SARS-CoV-2 Lambda, a variant of interest, has spread in some South American countries; however, its virological features and evolutionary traits remain unclear. In this study, we use pseudoviruses and reveal that the spike protein of the Lambda variant is more infectious than that of other variants due to the T76I and L452Q mutations. The RSYLTPGD246-253N mutation, a unique 7-amino acid deletion in the N-terminal domain of the Lambda spike protein, is responsible for evasion from neutralizing antibodies and further augments antibody-mediated enhancement of infection. Although this mutation generates a nascent N-linked glycosylation site, the additional N-linked glycan is dispensable for the virological property conferred by this mutation. Since the Lambda variant has dominantly spread according to the increasing frequency of the isolates harboring the RSYLTPGD246-253N mutation, our data suggest that the RSYLTPGD246-253N mutation is closely associated with the substantial spread of the Lambda variant in South America.

摘要

SARS-CoV-2 Lambda 是一种引起关注的变异株,已在一些南美国家传播;然而,其病毒学特征和进化特征尚不清楚。在本研究中,我们使用假病毒并揭示 Lambda 变异株的刺突蛋白由于 T76I 和 L452Q 突变而比其他变异株更具传染性。Lambda 刺突蛋白 N 端结构域独特的 7 个氨基酸缺失 RSYLTPGD246-253N 突变,负责逃避中和抗体,并进一步增强抗体介导的感染增强作用。尽管该突变产生了一个新的 N 连接糖基化位点,但该突变赋予的病毒学特性并不需要额外的 N 连接聚糖。由于携带 RSYLTPGD246-253N 突变的分离株的频率不断增加,Lambda 变异株已占主导地位传播,我们的数据表明,RSYLTPGD246-253N 突变与 Lambda 变异株在南美洲的大量传播密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/eaa1067464ff/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/ecb4bb59c4c6/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/4ebee4dff1d6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/c58707590d11/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/eaa1067464ff/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/ecb4bb59c4c6/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/4ebee4dff1d6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/c58707590d11/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698f/8683271/eaa1067464ff/gr3_lrg.jpg

相似文献

1
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance.SARS-CoV-2 Lambda 变体表现出增强的感染力和免疫抗性。
Cell Rep. 2022 Jan 11;38(2):110218. doi: 10.1016/j.celrep.2021.110218. Epub 2021 Dec 18.
2
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination.SARS-CoV-2 Lambda 变异株对感染和接种疫苗诱导的单克隆抗体和中和抗体的敏感性降低。
Emerg Microbes Infect. 2022 Dec;11(1):18-29. doi: 10.1080/22221751.2021.2008775.
3
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2.没有证据表明 Delta 亚谱系 AY.4.2 增加了细胞进入或抗体逃避。
Cell Mol Immunol. 2022 Mar;19(3):449-452. doi: 10.1038/s41423-021-00811-8. Epub 2022 Jan 5.
4
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.全面绘制 SARS-CoV-2 RBD 特异性中和抗体的结合热点,用于跟踪免疫逃逸变异株。
Genome Med. 2021 Oct 14;13(1):164. doi: 10.1186/s13073-021-00985-w.
5
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.新冠病毒感染 14 个月后 COVID-19 恢复期患者结合抗体和中和抗体的动态分析。
Front Immunol. 2021 Nov 26;12:793953. doi: 10.3389/fimmu.2021.793953. eCollection 2021.
6
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.SARS-CoV-2 从高中和性的 COVID-19 恢复期血浆中逃逸。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2103154118.
7
Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2.新型单克隆抗体和针对变异 SARS-CoV-2 的重组抗体
Front Immunol. 2021 Aug 30;12:715464. doi: 10.3389/fimmu.2021.715464. eCollection 2021.
8
Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential.SARS-CoV-2 刺突蛋白 N 端结构域中的突变热点赋予免疫逃逸潜能。
Viruses. 2021 Oct 20;13(11):2114. doi: 10.3390/v13112114.
9
The great escape? SARS-CoV-2 variants evading neutralizing responses.大逃亡?逃避中和反应的 SARS-CoV-2 变体。
Cell Host Microbe. 2021 Mar 10;29(3):322-324. doi: 10.1016/j.chom.2021.02.010.
10
Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants.糖基化掩盖棘突蛋白 NTD 和 RBD 表位可诱导针对 SARS-CoV-2 变体的广泛中和抗体。
Front Immunol. 2021 Dec 2;12:795741. doi: 10.3389/fimmu.2021.795741. eCollection 2021.

引用本文的文献

1
Molecular basis of potent antiviral HLA-C-restricted CD8 T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope.针对免疫显性的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳表位的高效抗病毒HLA-C限制性CD8 T细胞应答的分子基础
Nat Commun. 2025 Aug 28;16(1):8062. doi: 10.1038/s41467-025-63288-3.
2
Comprehensive N-glycosylation profiling of recombinant spike S1 protein from the wild-type SARS-CoV-2 and its variants.野生型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其变体的重组刺突S1蛋白的全面N-糖基化分析
Front Immunol. 2025 Jul 16;16:1592142. doi: 10.3389/fimmu.2025.1592142. eCollection 2025.
3
Loss of IgA and IgM Compromises Broad Neutralization of Structurally Divergent SARS-CoV-2 Variants.
IgA和IgM的缺失损害了对结构多样的新冠病毒变异株的广泛中和作用。
Antibodies (Basel). 2025 Jul 12;14(3):59. doi: 10.3390/antib14030059.
4
No Evidence of SARS-CoV-2 Infection in Urban Wildlife of Hokkaido, Japan.日本北海道城市野生动物中未发现感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的证据。
Transbound Emerg Dis. 2024 Aug 13;2024:1204825. doi: 10.1155/2024/1204825. eCollection 2024.
5
Evolutionary analysis and population dynamics in the global transmission of Kaposi's sarcoma-associated herpesvirus.卡波西肉瘤相关疱疹病毒全球传播中的进化分析与种群动态
Arch Virol. 2025 Mar 27;170(5):92. doi: 10.1007/s00705-025-06259-9.
6
SGV-caller: SARS-CoV-2 genome variation caller.SGV 调用器:严重急性呼吸综合征冠状病毒 2 基因组变异调用器。
Heliyon. 2025 Feb 12;11(4):e42613. doi: 10.1016/j.heliyon.2025.e42613. eCollection 2025 Feb 28.
7
Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient.一名免疫功能低下患者持续感染521天期间新冠病毒的适应性进化
NPJ Genom Med. 2025 Jan 17;10(1):4. doi: 10.1038/s41525-025-00463-x.
8
Features of Highly Homologous T-Cell Receptor Repertoire in the Immune Response to Mutations in Immunogenic Epitopes.免疫原性表位突变免疫应答中高度同源T细胞受体库的特征
Int J Mol Sci. 2024 Nov 23;25(23):12591. doi: 10.3390/ijms252312591.
9
Epi-Clock: A sensitive platform to help understand pathogenic disease outbreaks and facilitate the response to future outbreaks of concern.疫情时钟:一个有助于理解致病性疾病爆发并推动应对未来相关关注疫情的灵敏平台。
Heliyon. 2024 Aug 29;10(17):e36162. doi: 10.1016/j.heliyon.2024.e36162. eCollection 2024 Sep 15.
10
Early mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants in Chile.智利 SARS-CoV-2 Gamma 和 Lambda 变异株的早期突变特征和传播性。
Sci Rep. 2024 Jul 11;14(1):16000. doi: 10.1038/s41598-024-66885-2.